JEFFREY TATE, COO, Director at Cyclo Therapeutics, holds 92.04K shares in Cyclo Therapeutics (Ticker: CYTH). Most recently, JEFFREY TATE Bought $29,941 shares of Cyclo Therapeutics on Oct 23, 2023 for an estimated value of 21.26K.
What is the percentage of profitable transactions made by JEFFREY TATE?
The percentage of profitable transactions made by JEFFREY TATE is 20%.
What is the average return per transaction made by JEFFREY TATE?
The average return per transaction made by JEFFREY TATE is -30.60%.
What stocks does JEFFREY TATE hold?
JEFFREY TATE holds: CYTH stocks.
What was JEFFREY TATE’s latest transaction?
JEFFREY TATE latest transaction was an Informative Buy of $21.26K.
What was JEFFREY TATE's most profitable transaction?
JEFFREY TATE’s most profitable transaction was an Informative Buy of CYTH stock on April 24, 2023. The return on the trade was 62.50%.
What is JEFFREY TATE's role in Cyclo Therapeutics?
JEFFREY TATE's role in Cyclo Therapeutics is COO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.